ClinicalTrials.gg
CompletedNCT07886346Taif-COPDUpdated Oct 21, 2026

COPD Prevalence and Risk Factors Among Saudi Adults Over 18 in Taif

An observational study in Chronic Obstructive Pulmonary Disease (COPD), sponsored by Taif University. Completed at 1 site in Saudi Arabia. Open to participants aged 18 Years to 110 Years. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Taif University · Observational

Updated Oct 21, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
777
Ages
18 Years to 110 Years
Sex
All
01

Study summary

This cross-sectional study assesses the prevalence of previously diagnosed chronic obstructive pulmonary disease (COPD) and associated risk factors among Saudi adults aged 18 years and older living in Taif City, Saudi Arabia. Surveys and available medical records provide information on respiratory symptoms, smoking, environmental and occupational exposures, and medical history. The COPD Assessment Test (CAT) measures symptom burden. The study examines factors associated with COPD and respiratory symptoms to support local prevention and early detection efforts.

Read the detailed description

This observational, cross-sectional study examines chronic obstructive pulmonary disease (COPD) and associated demographic, clinical, behavioral, and environmental factors among Saudi adults residing in Taif City, Saudi Arabia. The study addresses limited local evidence concerning COPD in a high-altitude setting, with particular attention to exposures beyond tobacco smoking.

The protocol describes recruitment from community settings and major hospitals in Taif using systematic sampling, selecting every tenth eligible individual from hospital records and community registries. Information is collected through participant surveys and available medical records. Data include demographic characteristics, previous COPD diagnosis, respiratory symptoms, smoking history, secondhand smoke exposure, occupational hazards, indoor pollutants, biofuel and incense use, socioeconomic circumstances, and relevant respiratory medical history.

COPD status is based on a reported or documented previous clinical diagnosis. Spirometric confirmation is not incorporated into the survey; therefore, the study estimates the prevalence of previously diagnosed COPD and may not identify undiagnosed airflow obstruction.

Symptom burden is assessed using the eight-item COPD Assessment Test (CAT). Its domains include cough, sputum production, chest tightness, exertional breathlessness, limitations in daily activities, confidence leaving home, sleep, and energy. Each item is scored from 0 to 5, producing a total score from 0 to 40, with higher scores indicating greater symptom burden. The questionnaire is used to assess symptoms rather than establish a COPD diagnosis.

The minimum sample size was calculated using an assumed prevalence of 50%, a 95% confidence level, and a margin of error of 5%, yielding approximately 384 participants. The uploaded manuscript reports a final sample of 777 participants.

The statistical analysis uses SPSS version 26. Descriptive statistics summarize participant characteristics and exposures. Prevalence estimates are calculated with 95% confidence intervals. Associations between categorical variables and COPD status are examined using chi-square tests. Differences in symptom scores between groups are assessed using independent-samples t-tests and one-way analysis of variance. Statistical significance is defined as a p-value below 0.05. Because the study is cross-sectional, observed associations cannot establish causation.

The protocol specifies written informed consent before participation and confidential handling of personal information, with collected data used solely for research purposes.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disease (COPD)

Keywords

  • Chronic Obstructive Pulmonary Disease
  • COPD
  • Prevalence
  • Risk factors
  • Tobacco smoking
  • Secondhand smoke exposure
  • Indoor air pollution
  • Occupational exposure
  • Respiratory symptoms
  • Saudi Arabia
  • Taif
03

In context

Pulmonary Disease, Chronic Obstructive

4,252 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 707 are open to participants now.

This study's enrollment of 777 is above the median of 183 across 1,099 observational studies indexed under Pulmonary Disease, Chronic Obstructive.

Browse Pulmonary Disease, Chronic Obstructive studies →

Lead sponsor

Taif University is the lead sponsor of 16 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 110 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Saudi adults aged 18 years and older residing in Taif City, Saudi Arabia, recruited from community settings and major hospitals within the city. The population includes individuals with and without a previous diagnosis of chronic obstructive pulmonary disease.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Saudi nationals. Aged 18 years or older. Currently residing in Taif City, Saudi Arabia. Provide informed consent to participate.

Exclusion criteria

Exclusion Criteria:

Non-Saudi individuals. Individuals younger than 18 years. Individuals not currently residing in Taif City. Individuals who do not provide informed consent.

05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
777 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Prevalence of Previously Diagnosed Chronic Obstructive Pulmonary Disease

    Percentage of participants reporting a previous clinical diagnosis of chronic obstructive pulmonary disease, based on questionnaire responses and available medical records. Prevalence is calculated by dividing the number of participants with a previous diagnosis by the total number assessed and multiplying by 100, with a 95% confidence interval. No spirometric confirmation is performed.

    Time frame: single cross-sectional assessment

Secondary outcomes

  1. Associations Between Potential Risk Factors and Previously Diagnosed COPD

    Associations between previously diagnosed COPD and demographic characteristics, smoking history, secondhand smoke, occupational and environmental exposures, biofuel and incense use, socioeconomic status, and respiratory medical history, assessed using chi-square tests.

    Time frame: single cross-sectional assessment

07

Study locations

1 site
  • Taif university
    Ta'if, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2024 to primary completion in Sep 2026, 22 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 14, 2026
First posted
Oct 21, 2026
StartActual
Oct 24, 2024
Primary completionActual
Sep 20, 2026
CompletionActual
Sep 27, 2026
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07886346
Lead sponsor
Taif University
Responsible party
Naif Sultan Alhamyani (Medical intern, Taif University) — Principal investigator
First posted
Oct 21, 2026
Start date
Oct 24, 2024
Primary completion
Sep 20, 2026
Completion
Sep 27, 2026
Last update
Oct 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion